Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Simian virus 40 in humans.

Fernanda Martini1, Alfredo Corallini, Veronica Balatti

  • 1Department of Morphology and Embryology, Section of Cell Biology and Molecular Genetics, School of Medicine, and Center of Biotechnology, University of Ferrara, Via Fossato di Mortara, 64/B, 44100 Ferrara, Italy. tgm@unife.it

Infectious Agents and Cancer
|July 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.

The Journal of experimental medicine·2026
Same author

Bio-Oss<sup>®</sup>/Avitene™ composite scaffold promotes maxillofacial bone regeneration via early osteoimmunomodulation of BM-MSCs: an <i>in vitro</i> and clinical study.

Frontiers in bioengineering and biotechnology·2026
Same author

Hsa-microRNA-34a-5p inhibits virus-negative Merkel cell carcinoma cell proliferation and migration by regulating cell cycle- and EMT-related pathways and suppresses tumor spheroid formation.

Journal of dermatological science·2026
Same author

TG221: An Experimental Model for Liver Cancer Prevention and Treatment Approaches.

Biotech (Basel (Switzerland))·2026
Same author

Transcriptomic Analysis Reveals an NRF2-Mediated Redox and Metabolic Reprogramming in Sorafenib-Resistant Hepatocellular Carcinoma Cells.

Biotech (Basel (Switzerland))·2026
Same author

Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer.

Cell death discovery·2026
Same journal

CD44 expression associates with EBV LMP1, reduced CD8⁺ T cell infiltration, and lower PD-L1 combined positive score in nasopharyngeal carcinoma.

Infectious agents and cancer·2026
Same journal

Correlation between viral load and cervical squamous lesion severity in single and multiple infections: a large-scale analysis.

Infectious agents and cancer·2026
Same journal

Point-of-care hrHPV mRNA detection with reverse transcription recombinase polymerase amplification on a portable fluorimeter from provider-collected cervical samples in Maputo, Mozambique.

Infectious agents and cancer·2026
Same journal

Motivations and hesitations for cervical cancer screening: considerations for scale-up of human papilloma virus (HPV) testing within HIV care in Zimbabwe.

Infectious agents and cancer·2026
Same journal

Combined C-terminal truncation and point mutations in HBx in genotype D1 HBV-associated hepatocellular carcinoma.

Infectious agents and cancer·2026
Same journal

Acquired epidermodysplasia verruciformis presenting as isolated genital hypopigmentation in a renal transplant recipient: a rare case report.

Infectious agents and cancer·2026
See all related articles

Simian virus 40 (SV40), a monkey virus, may spread between people, potentially linking to certain cancers and kidney diseases. Research is ongoing to clarify its role in human health and disease.

Area of Science:

  • Virology
  • Oncology
  • Epidemiology

Background:

  • Simian virus 40 (SV40) was inadvertently introduced to human populations via contaminated vaccines.
  • Emerging evidence suggests potential contagious, horizontal transmission of SV40 in humans, independent of vaccine exposure.

Purpose of the Study:

  • To review current research on SV40 detection in human samples.
  • To evaluate the association between SV40 and human tumors or diseases.
  • To discuss the ongoing scientific debate regarding SV40's role in human health.

Main Methods:

  • Review of molecular biology and epidemiological studies.
  • Analysis of data on SV40 sequences in human tumors and blood samples.
  • Examination of prevalence data in healthy donors versus patients with specific conditions.

Related Experiment Videos

Main Results:

  • SV40 DNA has been detected in various human tumors, including brain and bone tumors, mesotheliomas, and lymphomas.
  • Higher prevalence of SV40 has been noted in individuals with specific cancers and kidney diseases compared to healthy donors.
  • Conflicting reports exist regarding SV40's circulation and its etiological role in human cancers.

Conclusions:

  • The presence and potential role of SV40 in human diseases remain subjects of scientific debate.
  • Further research is needed to definitively establish SV40's etiological contribution to human pathologies.
  • Understanding SV40 transmission and its impact on human health requires continued investigation.